1 enrolling by invitation. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Enrolling by invitation 1 |
Follow Fibromyalgia: new trials by email Literature Review of Fibromyalgia trials Research Report on Fibromyalgia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-Label Safety Study of AXS-14 in Subjects With Fibromyalgia AXS-14 (esreboxetine) - Fibromyalgia | Phase 3 | Enrolling by invitation | Axsome Therapeutics, Inc. | 300 | 2026-04-29 | 2026-11-06 |
Hyperalgesia (1)
Muscular Diseases (1) · Musculoskeletal Diseases (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Neuromuscular Diseases (1) · Pathological Conditions, Signs and Symptoms (1) · Rheumatic Diseases (1) · Sensation Disorders (1) · Signs and Symptoms (1) · Somatosensory Disorders (1)
esreboxetine (1)
United States (1)